Six venture kickers will fly to Boston for an investors’ roadshow in June 2017
21.04.2017
Dicronis, Lumigbo, MaxWell BioSystems, Medical Templates, RetinAI Medical and SensArs have been selected in the international business development program venture leaders Life Science 2017, in Boston. They will participate in a high powered, one week investors and business roadshow starting on June 11. Following the steps of Venture Kick startups such as InSphero or Amal Therapeutics, the six Swiss based Life Science entrepreneurs have developed breakthrough technologies that have the potential to attract international investors and business partners.
 Patrizia Marschalkova of Dicronis
|
 |
 Andreas Schmocker of Lumigbo
|
|
 Urs Frey of MaxWell BioSystems
|
|
 Rafael Hostettler of Medical Templates
|
|
 Carlos Ciller of RetinAI Medical
|
|
 From left to right: Francesco Petrini and Stanisa Raspopovic of SensArs
|
|
Dicronis, Patrizia Marschalkova (Medtech, ETHZ)
Lymphedema is a frequently occurring and serious complication of cancer therapies. It is a chronic and progressive disease, mostly outlined by the swelling of a limb due to improper function of the lymphatic system. The 2017 Venture Kick startup Dicronis helps to drastically improve its prognosis by providing the earliest lymphedema diagnostic based on a micro-needles technology used to assess the lymphatic function in a simple, safe, minimally-invasive and cost-effective manner.
Lumigbo, Andreas Schmocker (Medtech, EPFL)
Every day, more than 1 million implants are placed using open surgery. The venture kicker of 2016 Lumigbo developed a technology to build up implants inside the body using an access channel of less than half a millimeter in diameter. The procedure can be used for almost any type of polymer-based implant.
MaxWell BioSystems, Urs Frey (Micro technologies, Biotech, ETHZ)
The 2016 Venture Kick startup MaxWell Biosystems develops and distributes the most advanced electrophysiology cell-imaging platform for high-throughput assays to accelerate drug development. The toolset, consisting of an integrated sensor chip, acquisition hardware and software, delivers unprecedentedly accurate results. This solution can advance and accelerate drug discovery and basic neurosciences.
Medical Templates, Rafael Hostettler (Medtech, ETHZ)
The venture kicker of 2014 Medical Templates developed the “Puncture Cube”, an ingeniously simple approach to computed tomography guided needle navigation in the body for biopsies and pain therapy. Targeted at interventional radiologists, the technology reduces radiation, intervention time and variance, while increasing patient comfort and safety. The solution has seen extremely positive user feedback. MedicalTemplates is now aiming towards FDA approval by the End of 2017 to enter the US market.
RetinAI Medical, Carlos Ciller (Medtech, UNIL)
The 2016 Venture Kick startup RetinAI Medical is a startup based in Bern, Switzerland, focused on empowering eye care professionals and doctors using artificial intelligence. RetinAI uses the latest machine learning techniques (deep learning) and medical image processing to reach human-level performance for the assisted automatic evaluation of Optical Coherence Tomography (OCT), Fundus Image Photography and retinal Angiography. These techniques can be applied to the early detection and screening of the following pathologies: Age-related Macular Degeneration (AMD), Diabetic Retinopathy (DR), Glaucoma, and a multitude of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS).
SensArs, Francesco Petrini (Medtech, EPFL)
Lower limb amputees suffer from a lack of sensory feedback from prostheses. Because of this, they experience falls due to unexpected perturbations, and walk asymmetrically facing high fatigue. Also, they feel the prosthesis as a foreign body and contract phantom limb pain. Due to such inconveniences, 60% of the amputees abandon their prosthesis. SensArs’ solution is SENSY, a unique worldwide product which allows amputees to naturally feel their missing limbs. SensArs won the final of Venture Kick in 2017 together with another startup, Haelixa.
Lymphedema is a frequently occurring and serious complication of cancer therapies. It is a chronic and progressive disease, mostly outlined by the swelling of a limb due to improper function of the lymphatic system. The 2017 Venture Kick startup Dicronis helps to drastically improve its prognosis by providing the earliest lymphedema diagnostic based on a micro-needles technology used to assess the lymphatic function in a simple, safe, minimally-invasive and cost-effective manner.
Lumigbo, Andreas Schmocker (Medtech, EPFL)
Every day, more than 1 million implants are placed using open surgery. The venture kicker of 2016 Lumigbo developed a technology to build up implants inside the body using an access channel of less than half a millimeter in diameter. The procedure can be used for almost any type of polymer-based implant.
MaxWell BioSystems, Urs Frey (Micro technologies, Biotech, ETHZ)
The 2016 Venture Kick startup MaxWell Biosystems develops and distributes the most advanced electrophysiology cell-imaging platform for high-throughput assays to accelerate drug development. The toolset, consisting of an integrated sensor chip, acquisition hardware and software, delivers unprecedentedly accurate results. This solution can advance and accelerate drug discovery and basic neurosciences.
Medical Templates, Rafael Hostettler (Medtech, ETHZ)
The venture kicker of 2014 Medical Templates developed the “Puncture Cube”, an ingeniously simple approach to computed tomography guided needle navigation in the body for biopsies and pain therapy. Targeted at interventional radiologists, the technology reduces radiation, intervention time and variance, while increasing patient comfort and safety. The solution has seen extremely positive user feedback. MedicalTemplates is now aiming towards FDA approval by the End of 2017 to enter the US market.
RetinAI Medical, Carlos Ciller (Medtech, UNIL)
The 2016 Venture Kick startup RetinAI Medical is a startup based in Bern, Switzerland, focused on empowering eye care professionals and doctors using artificial intelligence. RetinAI uses the latest machine learning techniques (deep learning) and medical image processing to reach human-level performance for the assisted automatic evaluation of Optical Coherence Tomography (OCT), Fundus Image Photography and retinal Angiography. These techniques can be applied to the early detection and screening of the following pathologies: Age-related Macular Degeneration (AMD), Diabetic Retinopathy (DR), Glaucoma, and a multitude of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS).
SensArs, Francesco Petrini (Medtech, EPFL)
Lower limb amputees suffer from a lack of sensory feedback from prostheses. Because of this, they experience falls due to unexpected perturbations, and walk asymmetrically facing high fatigue. Also, they feel the prosthesis as a foreign body and contract phantom limb pain. Due to such inconveniences, 60% of the amputees abandon their prosthesis. SensArs’ solution is SENSY, a unique worldwide product which allows amputees to naturally feel their missing limbs. SensArs won the final of Venture Kick in 2017 together with another startup, Haelixa.